216 related articles for article (PubMed ID: 2187120)
1. Etoposide and teniposide in the treatment of acute leukemia.
Björkholm M
Med Oncol Tumor Pharmacother; 1990; 7(1):3-10. PubMed ID: 2187120
[TBL] [Abstract][Full Text] [Related]
2. Teniposide in lymphomas and leukemias.
Sonneveld P
Semin Oncol; 1992 Apr; 19(2 Suppl 6):59-64. PubMed ID: 1411640
[TBL] [Abstract][Full Text] [Related]
3. Epipodophyllotoxins in the treatment of childhood cancer.
Rivera GK; Pui CH; Santana VM; Pratt CB; Crist WM
Cancer Chemother Pharmacol; 1994; 34 Suppl():S89-95. PubMed ID: 8070034
[TBL] [Abstract][Full Text] [Related]
4. Teniposide in the treatment of leukemia: a case study of conflicting priorities in the development of drugs for fatal diseases.
Grem JL; Hoth DF; Leyland-Jones B; King SA; Ungerleider RS; Wittes RE
J Clin Oncol; 1988 Feb; 6(2):351-79. PubMed ID: 3276827
[TBL] [Abstract][Full Text] [Related]
5. Treatment strategies in relation to drug action.
Muggia FM; McVie G
NCI Monogr; 1987; (4):129-33. PubMed ID: 2819724
[No Abstract] [Full Text] [Related]
6. Etoposide in the treatment of leukemias.
Bishop JF
Semin Oncol; 1992 Dec; 19(6 Suppl 13):33-8. PubMed ID: 1492226
[TBL] [Abstract][Full Text] [Related]
7. Improved targeting of brain tumors using dexrazoxane rescue of topoisomerase II combined with supralethal doses of etoposide and teniposide.
Holm B; Sehested M; Jensen PB
Clin Cancer Res; 1998 Jun; 4(6):1367-73. PubMed ID: 9626452
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic trials with VP-16-213 and VM-26: active agents in small cell lung cancer, non-Hodgkin's lymphomas, and other malignancies.
Radice PA; Bunn PA; Ihde DC
Cancer Treat Rep; 1979 Aug; 63(8):1231-9. PubMed ID: 225026
[No Abstract] [Full Text] [Related]
9. Acute nonlymphoblastic leukemia in children treated for acute lymphoblastic leukemia with an intensive regimen including teniposide.
Verdeguer A; Ruiz JG; Ferris J; Esquembre C; Tasso MJ; Fernandez JM; Prieto F; Castel V
Med Pediatr Oncol; 1992; 20(1):48-52. PubMed ID: 1727211
[TBL] [Abstract][Full Text] [Related]
10. The epipodophyllotoxin teniposide in therapy for childhood acute lymphocytic leukemia.
Rivera GK
J Clin Oncol; 1988 Feb; 6(2):191-3. PubMed ID: 3276820
[No Abstract] [Full Text] [Related]
11. Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia.
Pui CH; Ribeiro RC; Hancock ML; Rivera GK; Evans WE; Raimondi SC; Head DR; Behm FG; Mahmoud MH; Sandlund JT
N Engl J Med; 1991 Dec; 325(24):1682-7. PubMed ID: 1944468
[TBL] [Abstract][Full Text] [Related]
12. [Cytosine arabinoside and VM-26 in induction treatment, failures and recurrences of childhood acute lymphoblastic leukemias].
Navajas Gutiérrez A; Bezanilla Regato JL; Moya Calderón E; Piñán MA
An Esp Pediatr; 1988 Oct; 29 Suppl 34():91-3. PubMed ID: 3214046
[No Abstract] [Full Text] [Related]
13. [New antineoplastic drugs of the podophyllotoxin derivative group].
Robak T; Płuzańska A
Pol Tyg Lek; 1983 Jan; 38(1):27-30. PubMed ID: 6346283
[No Abstract] [Full Text] [Related]
14. Optimizing antimetabolite-based chemotherapy for the treatment of childhood acute lymphoblastic leukaemia.
Estlin EJ; Lowis SP; Hall AG
Br J Haematol; 2000 Jul; 110(1):29-40. PubMed ID: 10930977
[No Abstract] [Full Text] [Related]
15. Clinical trials of teniposide (VM-26) in childhood acute lymphocytic leukemia.
Rivera GK; Evans WE
Semin Oncol; 1992 Apr; 19(2 Suppl 6):51-8. PubMed ID: 1411639
[TBL] [Abstract][Full Text] [Related]
16. [Phase II study of etoposide (NK 171) in advanced hematological malignancies].
Yoshida T; Nakanishi J; Ito K; Kobayashi S; Ohtake S; Nakamura S; Hattori K
Gan To Kagaku Ryoho; 1984 Aug; 11(8):1579-84. PubMed ID: 6476835
[TBL] [Abstract][Full Text] [Related]
17. Pediatric cancer chemotherapy: an updated review. I. Cis-Diammine--dichloroplatinum II (cisplatin), VM-26 (teniposide), VP-16 (etoposide), mitomycin C.
Gutierrez ML; Crooke ST
Cancer Treat Rev; 1979 Sep; 6(3):153-64. PubMed ID: 394834
[No Abstract] [Full Text] [Related]
18. Pharmacokinetics of continuous infusion of methotrexate and teniposide in pediatric cancer patients.
Rodman JH; Sunderland M; Kavanagh RL; Ochs J; Yalowich J; Evans WE; Rivera GK
Cancer Res; 1990 Jul; 50(14):4267-71. PubMed ID: 2194652
[TBL] [Abstract][Full Text] [Related]
19. Etoposide: a semisynthetic epipodophyllotoxin. Chemistry, pharmacology, pharmacokinetics, adverse effects and use as an antineoplastic agent.
Sinkule JA
Pharmacotherapy; 1984; 4(2):61-73. PubMed ID: 6326063
[TBL] [Abstract][Full Text] [Related]
20. Amsacrine alone or in combination with 5-azacytidine and etoposide in refractory or relapsed acute non lymphoblastic leukemia (ANLL).
Carella AM; Santini G; Martinengo M; Nati S; Giordano D; Congiu A; Cerri R; Damasio E; Risso M; Rossi E
Haematologica; 1985; 70(1):39-43. PubMed ID: 2408974
[No Abstract] [Full Text] [Related]
[Next] [New Search]